tiprankstipranks
RenovoRx (RNXT)
NASDAQ:RNXT
US Market

RenovoRx (RNXT) Income Statement

Compare
71 Followers

RenovoRx Income Statement

Last quarter (Q3 2024), RenovoRx's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, RenovoRx's net income was $-2.47M. See RenovoRx’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -6.00K$ -9.00K$ 0.00$ 0.00
Operating Expenses
$ 11.40M$ 9.95M$ 5.67M$ 3.20M$ 3.90M
Depreciation and Amortization
$ 6.00K$ 6.00K$ 9.00K$ 3.20M$ 3.90M
EBITDA
$ -11.39M$ -9.94M$ -5.66M$ 0.00$ 0.00
Operating Income
$ -11.40M$ -9.95M$ -5.67M$ -3.20M$ -3.90M
Other Income/Expenses
$ 1.16M$ 61.00K$ -653.00K$ -594.00K$ 57.00K
Pretax Income
$ -10.23M$ -9.89M$ -6.32M$ -3.80M$ -3.84M
Net Income
$ -10.23M$ -9.77M$ -7.10M$ -4.38M$ -3.78M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.99$ -1.08$ -0.79$ -0.51$ -0.44
Diluted EPS
$ -0.99$ -1.08$ -0.79$ -0.51$ -0.44
Weighted Average Shares Outstanding
10.29M 9.05M 8.93M 8.66M 8.66M
Weighted Average Shares Outstanding (Diluted)
10.29M 9.05M 8.93M 8.66M 8.66M
Currency in USD

RenovoRx Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis